Načítá se...
An update on antibody-based immunotherapies for Clostridium difficile infection
Clostridium difficile continues to be one of the most prevalent hospital-acquired bacterial infections in the developed world, despite the recent introduction of a novel and effective antibiotic agent (fidaxomicin). Alternative approaches under investigation to combat the anaerobic Gram-positive bac...
Uloženo v:
| Vydáno v: | Clin Exp Gastroenterol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4975149/ https://ncbi.nlm.nih.gov/pubmed/27536153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S84017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|